“To what extent could the rapid emergence of Hantavirus, a zoonotic disease, reshape financial markets and investment behaviour?”
India’s southern state of Kerala reported a new cluster of the Nipah virus in 2023 - a rare yet fatal zoonotic virus that can be passed to humans through bats. Geographically, India was able to contain the virus and prevent it from spreading elsewhere. However, this led to serious financial drawbacks, including hospitals activating emergency protocols, travel patterns briefly shifting, and Indian healthcare and pharmaceutical stocks seeing short-lived volatility as investors reassessed epidemiological risk. Although this was a relatively small outbreak compared to others like the Coronavirus, the market reaction was immediate and powerful.
Comparing the effects of the outbreak of the Nipah virus to COVID-19 creates a grey area, as the effects on the financial system were large enough to not be ignored, but not as catastrophic as COVID-19. This is sometimes linked to “black swan events,” where shocks are rare, unpredictable and outside normal expectations. However, applying this theory, an increasing number of zoonotic spillovers could indicate a bigger, long-term structural change, which is at the root of it all. Once considered biological anomalies, the growing number of zoonotic viruses, transmitted from animals to humans, has highlighted the effect of human actions, such as deforestation, industrial farming, and climate change.
This creates a challenge for investors, as the structure of the market moves towards embracing more frequent catastrophic disruptions compared to 20 years ago, when biological disruptions were less frequent. Therefore, it becomes harder for investors to learn from previous mistakes (such as COVID-19), as the fundamental market structure is constantly evolving. However, it remains unclear whether this shift is being properly reflected in asset prices or long-term risk models.
This essay argues that financial markets may be shifting away from pricing rare pandemic events and towards adapting to a new environment of recurring zoonotic spillovers. It explores the structural causes behind this shift, how key sectors may need to repricing risk, and how investor behaviour could adapt to a world where biological disruption, such as the new Hantavirus becomes a recurring feature rather than an exceptional one.
Why Hantavirus Emergence May Accelerate
Originally caused by rodents, the Hantavirus is a zoonotic virus transmitted to humans through airborne particles contaminated with rodent urine, saliva, and droppings. The recent and infamous strand of Hantavirus, found on the cruise ship is the Andes strain had a mortality rate of around 35% last year in Argentina. However, other more lethal strains such as Hantavirus Pulmonary Syndrome (HPS), have mortality rates of around 30–40%, which makes outbreaks seem more concerning. However, like Kerala’s Nipah Virus, most of Hantavirus’ historical outbreaks have been geographically isolated, however it has been especially common in parts of North and South America.
Although global tracking of hantavirus is still limited, evidence from different regions suggests that outbreaks are becoming more connected to environmental changes and are appearing in a wider range of locations. Cases of the Hantavirus have been reported across Argentina, Chile, Panama, and parts of Asia, with some outbreaks extending beyond isolated rural zones into more urban environments, suggesting that the conditions allowing the virus to spread from animals to humans are no longer limited to a few isolated regions. In addition, climate events such as El Niño have often been linked to sudden increases in rodent populations, making human exposure to the virus more likely.
A strong structural cause of this trend is that there are constant changes in the climate, where warmer temperatures and increased rainfall could cause rodents to live longer, thus leading to a rapid population growth. This could be seen during the 1993 Four Corners outbreak, where there was unusually heavy rainfall, linked to the El Niño conditions, which caused there to be a large availability of food. Eventually, this lead to a sharp rise in deer mouse populations carrying the virus. This proved the link between climate conditions, ecological disruption, and zoonotic emergence. Eventually putting the financial market at risk.
Moreover, urbanisation of rural regions via human actions like deforestation can lead to increased exposure to the virus. Expansion of agriculture, deforestation, and gradual settlement of people in untouched wildlife areas create chances for interaction between humans and carriers of the virus among rodents.
In addition, informal urbanisation, which is often characterised by poor sanitation and inadequate systems to control pests, can make the probability of transmission higher. All these factors indicate that the environment for spillover from animals to human beings is growing, and there is an increased chance that the financial market will be affected by biological shocks.
Conventional financial models tend to consider infectious disease epidemics as exogenous shocks that occur only very rarely. However, considering the increasing role of environmental factors in causing hantavirus infections, biological shocks could become a continuous threat to market stability. Just as markets had difficulty pricing systemic risks before the global financial crisis of 2008, financial organisations might also overlook the impact of continuous zoonotic disruptions.
Equity Markets & Sentiment-Driven Repricing
Hantavirus does not tend to cause large global disruptions to company earnings in the same way that a pandemic like COVID-19 does. Its impact is usually more localised, meaning it does not significantly affect overall corporate profits or global economic activity at scale. Nevertheless, the financial markets may still respond aggressively to the occurrence of the Hantavirus, not because of the damage to fundamentals, but because of the nature of how the market values expectations and not reality.
The first step in the dissemination of outbreak news is represented by information shock, which is characterised by the sudden appearance of news regarding zoonotic infections and their consequences on the public's well-being and health and which may be exacerbated by media reports on the matter. The ensuing uncertainty is immediately incorporated into the trading mechanisms through automatic algorithmic trading, and retail investor sentiment changes towards the conservative side, while institutional investors' withdrawal from risky assets in order to reduce their risk-exposure levels. Informational asymmetries play an important role during this period since investors have to act based on the limited amount of information.
It gives rise to opportunities for behavioural mispricing in the form of overreaction, whereby markets overestimate the global implications of what is actually a localised infection issue. Markets react to news by increasing volatility and selling securities in different sectors even when they have little relation to the outbreak in question, leading to overshooting, or in other words, prices falling far below their fundamental values. In the subsequent stage, however, the process of mean-reversion takes place when the information gets clearer and markets understand that long-term economic fundamentals are intact.
This kind of behaviour will lead to volatility clustering as well as an increase in cross-asset correlations in the short term. This means that in situations where there is a great deal of uncertainty, the behaviour of the markets is likely to assume a systemic risk perception in spite of the actual nature of the events being non-systemic. In the end, different asset classes that are completely different – health companies, emerging market equities, and agricultural equities – all tend to fall together.
For investors, sentiment-related distortions provide them with an opportunity to exploit some things. Macro hedge funds and volatility players will benefit from sentiment shifts, whereas quantitative investors will take advantage of any temporary mispricings and asset class dispersion. This means that investors need to make their investments by taking into account market reactions rather than long-term fundamentals. Indeed, alpha in this kind of environment will come out of the correct interpretation of market sentiments and not disease predictions.
Investor Behaviour & Financial Adaptation
The possibility of hantavirus-like pandemics and their recurrence may mean that when considering “ESG,” investors will move away from the usual considerations of carbon footprint and other similar parameters. Rather than looking at companies’ emissions, investors will consider biological and environmental risks through variables like climate variation, precipitation, land-use changes, farming development, and urban sanitation. All these variables contribute to creating the necessary environmental conditions for the transfer of diseases from animals. Consequently, an investor’s analysis will focus not only on business operations but also on the epidemiological and environmental risk transmission process.
This paradigm shift can further lead to a new reconsideration of the corporate efficiency model. Companies which work with “just-in-time” supply chains will be considered at increased risk due to their susceptibility to logistic shocks that occur unpredictably and nonlinearly. By contrast, those firms that value redundancy, diversification, and flexibility will gain in attractiveness. The focus for the investor’s interest may shift from the “just-in-time” supply chain to the “just-in-case” system.
Generally, hantavirus underscores the need for increased understanding of tail-risk events—highly unlikely but highly impactful events that pose difficulties for effective pricing by financial markets. Similar deficiencies in risk management occurred during the 2008 financial crisis, where the risks to the financial system were underplayed, and in climate-related financial risk, where future climatic changes are often dismissed. In the context of hantavirus, a single catastrophic event is not necessarily at play; rather, biological events may become increasingly common features of global financial uncertainty.
In light of this, there is an open question on investor behaviour: biological disruptions can result in shorter investment horizons as they increase uncertainty and dissuade investment of long-term capital. On the other hand, they may offer an opportunity for contrarian investors who are able to take advantage of temporary mispricings.
Conclusion
In addition to posing individual public health crises, the rise of hantavirus could signal a new trend toward perpetual biological volatility, driven by environmental pressures and climate disruption.
From the agricultural to the medical and insurance industries, financial markets may be structurally undervaluing the total exposure created by periodic zoonotic events. Investors are thus being pressured to factor in biological exposure and environmental resilience into their decision-making framework, which is traditionally built on economic uncertainty. In effect, markets designed to deal with discrete shocks will find themselves ill-equipped to address a reality defined by perpetual and ever-evolving biological risk.
This is hardly an uncommon systemic flaw. Similar to the years preceding the 2008 financial crisis, financial markets can undervalue risk when each risk component appears relatively unlikely, even when combined, to produce a material structural exposure. Biological risks may similarly be underestimated for precisely that reason – being disparate and sporadic in nature.
Ultimately, investors expecting the next “COVID-level” shock will fail to recognise a much deeper structural transition: the integration of perpetual biological risk into the core structure of the global financial market system.